Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 2 sources · 29 days · First seen about 1 month ago · Last updated 5 days ago

Intuitive Surgical corporate governance and financial status

Overview

Intuitive Surgical has undergone recent corporate governance updates and experienced fluctuations in its financial performance and stock valuation.

In July 2026, the company implemented changes to its corporate bylaws regarding shareholder nomination rules, voting standards, and special general meeting conditions. During this period, Director Amy Ladd executed a pre-arranged Rule 10b5-1 trading plan to sell 72 shares of stock.

While the company reported strong quarterly earnings—including a revenue increase of approximately 18.4 to 19 percent driven by a rise in worldwide procedures using da Vinci and Ion systems—its stock price faced downward pressure. By early September 2026, shares fell below $370, a level significantly lower than both the previous year’s price and average analyst targets, despite reported adjusted earnings per share of $2.80.

Entities

Nasdaq · Amy Ladd · Securities and Exchange Commission · Intuitive Surgical · Intuitive Surgical, Inc.

Timeline

5 days ago

[BUSINESS] 2 sources
Intuitive Surgical stock falls below $370 despite strong quarterly earnings
Intuitive Surgical shares fell below $370 despite Q2 2026 revenue rising 19 percent to $2.89 billion, driven by growth in da Vinci and Ion system procedures.
about 1 month ago

[BUSINESS] 3 sources
Intuitive Surgical updates corporate bylaws and reports insider stock sale
Intuitive Surgical has updated its corporate bylaws regarding shareholder nominations and voting, while Director Amy Ladd executed a pre-arranged sale of 72 shares.

Sources

ad-hoc-news.de · finanznachrichten.de